The Nasdaq-100 may be trading close to record territory, but the strength of the headline index tells only part of the story. Several well-known growth stocks remain more than 50% below their all-time highs, creating a striking divide between the index's biggest winners and its most severely damaged constituents.

This divergence matters for investors. A stock that has fallen 50%, 70%, or even 90% is not automatically cheap. Some declines reflect a temporary business cycle, while others reveal deteriorating margins, fading competitive advantages, or a permanently lower valuation. The most compelling opportunity may not lie in finding the stock with the largest decline, but rather in identifying which companies retain the earnings power, balance sheet, and competitive position necessary to recover.

A Strong Index Can Hide Severe Weakness Underneath

The Nasdaq-100 is a modified market-capitalization-weighted index tracking the 100 largest non-financial companies listed on the Nasdaq exchange. Its construction means larger companies exert far greater influence on its direction than smaller constituents. Gains in companies such as Nvidia, Microsoft, Apple, Amazon, and Alphabet can keep the index elevated even while numerous individual stocks experience deep bear markets. This concentration effect has been documented across multiple market cycles: when a handful of megacap companies rally strongly, headline index performance can diverge sharply from the experience of the median constituent.

This creates an important distinction: the Nasdaq-100 can remain technically bullish as an index while a meaningful group of its components simultaneously remains in long-term downtrends. Investors buying the index receive very different exposure from investors attempting to select its most heavily discounted stocks. The index, therefore, does not necessarily provide a complete picture of the average company beneath the surface.

Nasdaq Stocks With Especially Deep Drawdowns

The following examples are based on approximate prices around the July 29, 2026 close. These figures are not an exhaustive screen, and historical peaks may require adjustment for stock splits, corporate actions, or changes in index membership. Nevertheless, the dispersion between top performers and laggards is too large to dismiss as ordinary market noise.

Why a 50% Decline Requires More Than a 50% Recovery

One of the most frequently misunderstood aspects of drawdowns is the mathematics of recovering from them. A stock that falls from $100 to $50 has lost 50%, but it must double to return to $100. After a 90% decline, the remaining position must rise ninefold merely to revisit its old high.

This is why anchoring to a former share price can be dangerous. The previous peak does not represent fair value simply because the stock traded there before. This asymmetry is one reason why deep drawdowns in individual stocks can persist for years rather than resolving quickly: the math works against investors who assume that a partial rebound is sufficient.

Which Declines May Be Cyclical?

Some companies experience deep drawdowns because their industries move through powerful boom-and-bust cycles. The semiconductor sector in particular has a well-documented history of these cycles, with periods of supply shortages and surging demand alternating with inventory buildups and pricing pressure.

SanDisk is an especially dramatic example. The stock reached $2,354.39 during an extraordinary rally fueled by demand for memory and storage connected to AI infrastructure. Its subsequent fall toward $1,016 represents a decline of almost 57% in little more than a month. However, this is not the conventional story of a stagnant company in long-term decline. SanDisk remains far above where it began its historic rally, and its drawdown may tell investors more about extreme prior expectations and profit-taking than about the long-term disappearance of storage demand.

For investors, the key questions are: Is memory demand merely pausing after an exceptional expansion? Are selling prices and margins beginning a normal cyclical downturn? Has the market moved from underestimating AI storage demand to overestimating it? Can earnings grow into the valuation even if the share price does not revisit its peak?

Semiconductor investors should pay particular attention to inventories, contract pricing, production capacity, and customer capital-expenditure plans. Those indicators can reveal whether a decline is a temporary digestion phase or the beginning of a deeper earnings contraction.

Which Declines May Signal Structural Deterioration?

Other stocks face problems that cannot be solved simply by waiting for the economic cycle to improve.

PayPal still processes an enormous volume of payments, but the quality of that volume matters. Lower-margin unbranded processing can increase total payment volume without producing the economics investors once associated with PayPal's branded checkout business. This dynamic reflects a broader competitive shift in the payments industry, where scale and pricing pressure have compressed margins across multiple segments. For PayPal investors, the decisive questions are not whether digital payments will continue growing, but whether the company can protect transaction margins, strengthen branded checkout, and convert payment growth into durable free cash flow.

Lululemon presents a different challenge. Its decline reflects questions about North American growth, product execution, promotional activity, and competition in premium athletic apparel. A lower price-to-earnings ratio may look attractive, but only if earnings expectations have fallen far enough. The premium athleisure category has also seen increased competition from both established brands and newer entrants, adding pressure on pricing and customer loyalty.

Moderna faces perhaps the clearest revenue-transition problem. The extraordinary demand created by the pandemic has passed, while the company must continue funding an expensive development pipeline. Its recovery case depends increasingly on whether new products can replace a meaningful portion of lost COVID-related revenue. This is a pattern observed across biotech companies that experience a surge of revenue from a single product: replacing that revenue stream with a diversified pipeline is a multi-year process with uncertain outcomes.

Enphase combines cyclical and structural pressures. High financing costs have reduced the affordability of residential solar systems, while regulatory changes and excess channel inventory have intensified the downturn. The residential solar industry has historically shown sensitivity to interest rates and policy shifts, making it difficult to separate temporary headwinds from lasting changes in demand. Lower interest rates could help demand, but investors must still determine whether the company can restore revenue growth and margins in a changed market.

Four Tests for Separating an Opportunity From a Value Trap

Instead of buying solely because a stock is far below its high, investors can examine four areas:

1. Is revenue stabilizing? A falling stock can recover before revenue returns to growth, but evidence of stabilization is usually needed. Investors should compare management guidance, analyst estimates, and sequential results rather than relying only on year-over-year numbers distorted by an earlier boom.

2. Are margins temporarily or permanently lower? Temporary margin pressure may come from excess inventory, low factory utilization, or short-term promotional activity. Structural margin pressure arises when competition, commoditization, or lost pricing power permanently changes the business.

3. Can the balance sheet fund the recovery? Companies with ample cash and positive free cash flow can survive a long repair process. Highly leveraged businesses or companies burning cash may need to issue shares, refinance debt, or reduce investment before the recovery arrives.

4. What evidence would invalidate the bullish thesis? Investors should decide in advance what would prove their analysis wrong. That could include another guidance reduction, accelerating market-share losses, deteriorating free cash flow, or a failure to meet an important product milestone. An investment thesis without an invalidation condition can easily become an emotional attachment to a falling stock.

What This Divergence Says About the Wider Market

The divide between the Nasdaq-100 and its deeply impaired stocks has several broader implications.

First, it confirms that this is a highly selective market. Capital is rewarding a relatively narrow group of companies with visible earnings growth, strong AI exposure, or dominant competitive positions.

Second, it creates opportunities for active investors, but also raises the difficulty level. Buying the weakest stocks indiscriminately may produce very different results from owning the index.

Third, breadth can act as an early warning signal. If more constituents begin joining the leaders, the rally becomes healthier. If weakness spreads while the largest companies continue holding up the index, concentration risk becomes more important. Market historians note that episodes of extreme index concentration and narrow leadership have, at times, preceded periods of rotation or volatility, though timing and outcomes have varied considerably.

The Investor Conclusion

The Nasdaq-100's strength and the severe drawdowns inside it are not contradictory. They are two sides of a market increasingly driven by concentration and company-specific execution.

Deeply discounted stocks may eventually produce some of the market's strongest recoveries, but the size of the decline alone is not the opportunity. The real opportunity appears when a company's competitive position and earnings potential are more resilient than its share price suggests.

For investors examining SanDisk, PayPal, Lululemon, Moderna, Enphase, or other damaged growth stocks, the central question should not be, "How far is this below its high?" A more useful question is: What must improve for earnings, cash flow, and investor confidence to justify a durable recovery, and is there evidence that improvement has begun?

That distinction may separate tomorrow's recovery leaders from the stocks that remain cheap for a reason.

Stock prices and drawdown estimates are approximate snapshots based on market prices around July 29, 2026. They may change rapidly and should be independently verified before making any investment decision.

Source: Investinglive